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Abstract
Background: Urinary incontinence (UI) in women is a chronic disorder which has a negative impact on health-
related quality of life. Only 45 % of the affected individuals report the problem with continence to their doctor. The
aim of the study was to assess the duration of stress urinary incontinence (SUI), time from disease onset to the first
medical consultation and in-depth diagnosis, as well as the need for using continence pads in various grades of
SUI.
Methods: We conducted a cross-sectional study in women who presented at the urogynecologic ambulatory
center and reported urinary incontinence. A total of 420 subjects were interviewed and underwent urogynecologic
and urodynamic examinations. A group of 147 patients with urodynamic SUI was enrolled in the study.
Results: All women were graded according to the Stamey severity score: grade 1 – 56 (38.1 %), grade 2 – 68
(46.3 %), and grade 3 – 23 (15.6 %). Mean time elapsed between disease onset and presentation at the
urogynecologic ambulatory center was 17.4 ± 11.8 years (grades 1, 2 and 3 for 11.6 ± 11.8, 14.9 ± 10.8, and 22.2 ±
12.1 years, respectively; p = 0.0002). Patients with SUI started perceiving their condition as a problem 4.7 ± 5.4 years
before referral to urodynamics; 58.3 % of the SUI patients reported their problems with continence to a physician.
Average time between the onset of UI symptoms and seeking medical help was 13.28 ± 12.3 years. Mean duration
of using continence pads during the day was 4.2, 5.4 and 10.2 years in grades 1, 2 and 3, respectively (p = 0.0002).
The number of patients using continence pads in and outside the home, as compared to outside only, was: grade
1 – 44.6 % vs. 28.6 %, grade 2 – 77.6 % vs. 13.4 %, and grade 3 – 86.4 % vs. 9.1 % (p = 0.004). Mean use of
continence pads at night was 3.3, 6.1, and 9.1 years in grades 1, 2 and 3, respectively. The differences were not
statistically significant. Protective continence products were used at night by 26.7 % of the SUI patients: 16.1 %,
25 % and 59.1 % in grades 1, 2 and 3, respectively (p = 0.004).
Conclusions: Women with SUI delay seeking medical help for over a decade. The severity of SUI is associated with
duration and increased use of continence pads.
Keywords: Stress urinary incontinence, Urinary leakage, Incontinence pads, Female, Disease progression, Health
care seeking behavior, Age at onset, Urodynamics
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Background
Urinary incontinence (UI) is a chronic condition affect-
ing approximately 16.8 % of the Polish female population
but, due to the embarrassing nature of the problem, the
data are believed to be underestimated [1]. According to
other epidemiological and clinical studies, 10-44 % of all
women develop UI or other urogynecologic problems,
which is associated with several risk factors or contribut-
ing variables [2–4]. These data suggest that UI should be
perceived as a health problem which markedly influ-
ences the lives of the affected people.
Depending on patient cultural background, UI has
been treated either as a symptom of aging (49.5 %), or
an inevitable consequence of childbirth (51.9 %) [5].
According to Kinchen et al. [6], only 38 % of women
mention their current problems with UI during a doc-
tor’s appointment, whereas the conversation about UI is
initiated by the physician in only 7 % of the cases. Thus,
over half of American women will remain silent about
their struggle with incontinence during a medical
appointment. Some women are convinced they can
manage with the problem themselves (22.2 %), others do
not believe in treatment possibilities (13.7 %) [7]. The
greater the severity and frequency of UI symptoms, the
more willingly the patients talk about UI. According
to Hannenstad et al. [8], only every fourth UI patient
seeks help.
Incontinent women turn to doctors of various special-
ties. According to data from the U.S., they usually con-
sult their GP (42.9 %), an obstetrician/gynecologist
(35.1 %), and an internist (10.9 %), whereas only 4.4 %
would address a urologist [9]. Mean age of women with
UI who seek medical care is significantly higher than
their peers who do not seek help (56.9 vs. 51.8, p < 0.01)
[6, 8, 10]. Patients with urgent or mixed urinary incon-
tinence are more likely to seek help than women with
stress urinary incontinence (SUI) [9, 10]. Women who
get regular checkups or those with comorbid diseases
seek treatment more often [6]. Undoubtedly, the feelings
of shame or guilt are the reason for lack of doctor-
patient communication. According to Saleh et al. [5], it
applies to 54 % of women with UI. A similar proportion
of female patients consider UI to be too shameful to dis-
cuss it with their husbands (56 %). Numerous studies
confirmed that patients seeking medical help have sig-
nificantly lower self-perceived health-related quality of
life (HRQoL) in comparison to women who do not re-
port the problem to their doctor [10, 11].
According to Temml et al. [12], 65.7 % of the affected
women report a negative impact of UI on HRQoL.
Changes in the behavior relate to most areas of everyday
activity: social, psychological, occupational, domestic,
physical, and sexual [13]. HRQoL impairment signifi-
cantly correlates with the frequency of urinary leakage
episodes, severity of incontinence, and the need to use
continence pads (p < 0.01) [12]. UI in the elderly causes
social isolation, increases psychological distress and costs
(continence products, detergents), and often contributes
to a growing number of admissions to nursing homes
[6]. The use of incontinence products generates great
additional costs and constitutes an additional financial
burden both, for the patients and the health care system.
In the U.S., approximately 70 % of the total cost of UI
(of $12.4 billion) is related to routine care, e.g. absorbent
products [14]. In Poland, the ratio are different, the
annual UI-related cost amounts to 2 billion PLN, in-
cluding 270 million PLN (13.5 %) for incontinence
products alone.
The primary aim of our study was to measure time
elapsed before UI women decide to consult a doctor
and receive in-depth diagnosis. The secondary aim
was to analyze the usage of continence pads in vari-
ous grades of SUI. It is an important issue and it
may help to calculate the disease-related costs before
effective treatment is applied.
Methods
We conducted a cross-sectional study in women who
presented at the urogynecologic ambulatory department
between 2001 and 2006 and reported problems with UI.
A detailed medical history was taken with the emphasis
on UI (including a thorough analysis of the current fre-
quency of urine leakage, situations in which they occur,
current need for using continence pads, and the mictur-
ition pattern). The patients also submitted information
about the time of UI onset, symptom severity, and treat-
ment received so far. Each subject was asked to prepare
a 48-h voiding diary. Urogynecologic examination was
conducted and pelvic organ prolapse was assessed ac-
cording to the Pelvic Organ Prolapse Quantification
(POP-Q) system. Negative urine culture was the require-
ment for urodynamic examination, performed with the
Solar® equipment (Medical Measurement System, The
Netherlands) and in accordance with the standards of
the International Continence Society [15]. The inclusion
criterion was urodynamically confirmed pure SUI, pa-
tients with mixed and urge UI were excluded. In a group
of 420 patients with UI, 264 women were diagnosed with
SUI. As the study was a part of the research on HRQoL
in patients with UI, participants who refused to consent
were excluded. Thus, a group of 147 women were
assessed (response rate of 55.7 %). After the diagnosis,
the patients were graded according to the Stamey score,
i.e. grade 1 - urine leakage on strong physical effort
(coughing, sneezing), grade 2 - medium effort (change of
position) and grade 3 – urine leakage on minimal effort
(lying position) [16].
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The study was approved by the Ethics Committee of
the Medical University of Gdańsk, and all patients gave
their verbal informed consent to take part in the study.
The privacy of participants was maintained. The Declar-
ation of Helsinki was followed.
Statistical analysis
The statistical analysis was performed with STATISTICA
version 10. All continuous variables were expressed as
mean ± SD. Categorical variables were expressed as per-
centages of the total group. A p-value of <0.05 was consid-
ered as statistically significant. Differences in continuous
variables were initially assessed with Levene’s test for
homogeneity of variance. Analysis of variance was per-
formed for more than two groups, the Kruskal-Wallis test
was used for variance inequality or lack of variance homo-
geneity. Post-hoc tests were employed for statistically sig-
nificant results. The comparison of the ordinal variables of
the two groups was performed with the Mann–Whitney
U test, and in case of more than two groups with the
Kruskal-Wallis test and post-hoc analysis, if appropriate.
Comparisons of categorical variables were performed
using Chi-square test, Chi-square test with Yates continu-
ity correction or Fisher’s exact test.
Based on data from the literature [6] it may be
expected, that frequency of reporting the problem of UI
to the doctor will be about 38 %. To achieve required
precision of 8 % required sample size was 142 patients.
Results
Table 1 presents the percentage of patients with particu-
lar grades of SUI according to the Stamey score. As far
as POP (evaluated with the POP-Q system) is concerned,
stage 0 was diagnosed in 9 (6.1 %), stage I in 24 (16.3 %),
stage II in 103 (70.1 %), and stage III in 11 (7.5 %) pa-
tients. No stage IV POP-Q cases were found. Mean age
was 53.89 ± 9.5 years (range 24 – 83), mean BMI was
27.0 kg/m2 ± 4.8. In the analyzed group, 99.3 % of the
women were parous, 3 reported no vaginal delivery,
among them 2 were nulliparous. Fifty patients (34 %)
were premenopausal and 97 (66 %) were postmeno-
pausal. Mean age at menopause was 49.16 ± 4.8 years
(range 30–58). Thirty-four of the postmenopausal pa-
tients reported past or current use of hormone replace-
ment therapy.
In the postmenopausal group, 47 patients reported symp-
tom onset after menopause: 15 - within a year of the last
menstrual bleeding, 13 - in the following year, 5 - within
5 years, and 14 - in the subsequent years. UI occurred after
menopause within 7.5 ± 7.9 years (range 0–29 years).
Study subjects have suffered from UI for 17.4 ±
11.8 years (range 1–55 years). The duration of UI, in
particular SUI grades 1–3 was 11.6 ± 11.8, 14.9 ± 10.8,
and 22.2 ± 12.1 years, respectively. Significantly longer
duration was found in patients with grade 3 as compared
to grades 1 or 2 (p = 0.002 and p = 0.00003, respectively).
Ten patients (6.8 %) suffered from symptoms of stable
intensity. As a result of the urodynamic studies, 8 of
them were diagnosed with grade 1 and 2 with grade 2 of
SUI. The remaining 137 patients (93.2 %) reported pro-
gression of symptoms in the course of 5.27 ± 5.3 years
(range 0.5–26 years) before presenting at an urogyneco-
logic ambulatory center. The disease had been a problem
for 4.7 ± 5.4 years before the affected women underwent
urodynamic examination (range 0.5–30 years).
Sixty (41.6 %) SUI patients presented directly at an
urogynecology center, while 84 (58.3 %) reported prob-
lems with UI to their gynecologist, urologist or GP (3
patients did not submit their data). Average time be-
tween symptom onset and reporting UI to a physician
was 13.28 ± 12.3 years, and between informing the doc-
tor and the diagnostic tests was 3.87 ± 4.6 years (range
0.5–22 years). Time elapsed between consulting the
physician and thorough diagnostic tests also did not dif-
fer significantly in particular grades of SUI (Table 2).
In our study, time elapsed between symptom onset
and informing the doctor depended significantly on the
severity of incontinence at diagnosis. Grade 3 SUI pa-
tients delayed reporting their problem to the doctor
Table 1 Pre- and postmenopausal patients (Stamey
incontinence score of SUI)
Grades
of SUI
Premenopausal patients Postmenopausal patients
n n % n %
1 56 23 46.0 33 34.0
2 68 19 38.0 49 50.5
3 23 8 16.0 15 15.5
Total 147 50 97
p >0.05
p - level of significance for Chi-square test with Yates continuity correction












the doctor and thorough
diagnostic tests
(n = 84) (years ± SD) (years ± SD)
n %
1 33 60.0 % 13.1 ± 12.5 3.3 ± 4.6
2 36 52.9 % 12.8 ± 11.5 4.5 ± 4.9
3 15 71.4 % 23.0 ± 12.8 3.5 ± 3.4
p >0.05a 0.002b,c 0.19b
alevel of significance for Chi-square test
blevel of significance for Kruskal-Wallis test
cDuncan post-hoc analysis in particular grades of SUI: 1 vs. 3, p = 0.0002, 2 vs.
3, p = 0.003
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significantly longer than women with grades 1 and 2 SUI
(p = 0.0002 and 0.003, respectively).
Patients with higher grades of SUI had to use contin-
ence pads during the day significantly longer (grade 1 > 4,
grade 2 > 5, and grade 3 > 10 years). Women using contin-
ence pads in and outside the home had a significantly
higher severity of incontinence than those using protective
pads only outside the home (p = 0.004). Grade 1 was most
frequently observed in subjects using continence pads
only outside the home, whereas 4.8 % of SUI patients, all
grade 1, needed no incontinence protection (Table 3).
The use of continence pads at night (in years) in-
creased with the severity of SUI, but the difference was
not statistically significant. Thirty-nine patients (26.7 %)
reported the need for sanitary protection at night, in-
cluding 6 patients using adult diapers. Protective pads at
night were mostly used by grade 3 SUI women. Among
subjects reporting the use of continence pads at night
only 23.1 % were grade 1, whereas 43.6 % and 33.3 %
were grades 2 and 3, respectively (Table 4).
Discussion
In our study, over half (58.3 %) of the SUI patients re-
ported continence problems to their doctor, while the
rest received information about diagnostic tests and
therapy from media or friends. In the U.S., that number
is estimated at 38–45 % [6, 17]. According to Kinchen et
al. [6], patients with severe UI are three times more
likely to seek medical help than their peers with moder-
ate severity of UI (OR 4.13, 95 % CI 1.35–12.59 vs. OR
1.39, CI 1.00–1.94). In our study, there were no signifi-
cant differences in the rate of women seeking medical
advice in grades 1 and 2 SUI, but we observed a ten-
dency to inform the doctor about continence problems
much more frequently in grade 3 patients. Kinchen et al.
[6], confirmed that an increase in the number of women
reporting the disease to the doctor corresponds to dis-
ease duration. Our study showed that women with grade
3 SUI delayed contact with the doctor the longest, as
compared to their peers with grades 1 and 2 SUI.
The prevalence rate of UI in postmenopausal women
ranges from 34.6 to 50 % [1, 18]. In our study, postmen-
opausal patients accounted for 66 % of the SUI group.
Premenopausal patients developed grade 1 SUI more
often than their postmenopausal peers (46 and 34 %, re-
spectively), grade 2 was more common among postmen-
opausal women (50.5 vs. 38 %), but the difference was
not statistically significant. A similar percentage of pa-
tients in both groups were diagnosed with grade 3 SUI.
Our research was conducted in the first decade of this
century, i.e. at the time of the awareness campaign about
urogynecology in Poland and growing access to urody-
namic testing, resulting in new diagnostic possibilities.
Women who had been suffering from UI for years de-
cided to seek help, probably due to escalating symptoms
connected with disease progression. UI is accompanied
by fear of public manifestation of symptoms and poten-
tially shameful situations, leading to deteriorated quality
of life [10]. Patients frequently admit that previously
used methods (e.g. fluid restriction, frequent voiding,
keeping the pelvic floor muscles in constant tension,
etc.) are no longer sufficient to fully control the symp-
toms of UI, which prompts them to seek help.
U.S. studies confirmed the use of continence pads in
42 %, frequent emptying of the bladder in 33.5 %, and
fluid restriction in 23.3 % of the affected individuals [9].
In our study, among patients presenting for urogyneco-
logic examination, the rates of women constantly using
continence pads during the day and at night were 66.2
and 26.7 %, respectively. We performed a detailed ana-
lysis of the circumstances and types of continence pads
used by SUI women. None of the patients with SUI
grade 2 and higher risked using no protection during the
day. The group of patients who changed underwear after
leakage were usually people of lower income. Women
with excellent preventive methods, who understand the
pathophysiology of UI and can predict situations with
Table 3 Use of continence pads during the day in SUI patients
Grades
of SUI
Methods of protection against UI Duration of use
of continence padscontinence pads change of
underwear
none
in and outside the home only outside the home occasionally hygiene reasons
n n (%) n (%) n (%) n (%) n (%) n (%) (years ± SD)
1 55 25 (44.6) 16 (28.6) 1 (1.8) 3 (5.4) 4 (7.1) 7 (12.5) 4.2 ± 6.5
2 68 52 (77.6) 9 (13.4) 2 (3.0) - 4 (6.0) - 5.4 ± 3.9
3 22 19 (86.4) 2 (9.1) 1 (4.5) - - - 10.2 ± 8.9
Total 145 96 27 4 3 8 7
p 0.004a 0.0002b
2 patients did not provide information
alevel of significance for the Mann–Whitney U test
blevel of significance for ANOVA rank Kruskal-Wallis test, independent variable severity of SUI
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leakage, were occasional users of incontinence products.
Diokno et al. [9], divided coping strategies for UI into
defensive or intended to hide urinary incontinence.
Methods aiming at preventing urine leakage cause limi-
tation of physical and social activity. Urine leakage can
be hidden by frequent washing, change of underwear,
use of absorbent materials (protective perennial pads, di-
apers), or wearing dark and long clothes to hide the
stains [5, 9].
SUI has been suggested to be progressive, but the lit-
erature lacks conclusive reports. Lifford et al. [19], inves-
tigated females with UI (aged 54–79) for 2 years and
proved disease progression in 32.1 %, reduction of symp-
toms in 8.9 %, and complete symptom remission in 2 %
of the women. However, their analysis did not involve
pelvic organ prolapse assessment, which may mask or
reduce the severity of SUI, leading to occult UI. Our
analysis revealed a significant relationship between dis-
ease duration and severity. Mean disease duration in
grades 1–3 was 11.6, 14.9, and 22.2 years, respectively.
Irwin et al. [20], who conducted a meta-analysis of ar-
ticles published between 1990–2009, support the hy-
pothesis of dynamic development and persistence of UI
symptoms. They draw attention to the lack of uniformity
in collecting information from the affected patients, the
form (questionnaire) of the population studies, and
assessing the discomfort by means of a self-report.
Herzog et al. [21], during a 2-year follow-up of patients
>60 years of age, confirmed the annual incidence of UI
in 20 % of the study population. Additionally, Townsend
et al. [17], examined a group of women between 36 and
55 years and recognized UI as a dynamic process, esti-
mating that 1 out of 7 continent women will have
suffered from UI, at least once a month, by the end of a
1-year observation period.
An advantage of our study is the complete diagnostic
process involving urodynamic tests, which also allowed
us to analyze and compare the symptoms reported by
patients. Disease duration is directly related to how long
(in years) continence materials have been used, which in
our study was 4.2, 5.4 and 10.2 during the day in grades
1–3 of SUI, respectively. Women using incontinence
protection only outside the home are much more likely
to be grade 1 SUI according to the Stamey score,
whereas patients using continence pads at night are sig-
nificantly more frequently diagnosed with grade 3 SUI.
In the questionnaire survey by Diokno et al. [9], involv-
ing a large population of American women with various
types of UI, 84 % of the subjects reported the use of con-
tinence materials, including 5.2 % using adult diapers. In
our study group the results were similar, with only 6.9 %
of women reporting no incontinence protection during
the day but 4.1 % using diapers at night. The everyday
usage of continence pads is not only a significant cost,
but also a factor strongly contributing to deteriorated
HRQoL in UI patients [12].
Cross-sectional design and patient recall for data col-
lection about the beginning of UI constituted two major
limitations of our study. However, women very often as-
sociate the onset of UI with particular points in their
lives, i.e. pregnancy, childbirth, menopause, which facili-
tates time estimation.
According to Kinchen et al. [6], less than half of UI
patients admit to incontinence problems during check-up.
Some authors draw attention to the fact that not all doc-
tors have the necessary knowledge about the issue, and
sometimes they avoid the topic for fear of making the pa-
tients uncomfortable. In a study conducted among doc-
tors in Oklahoma, 50 % of GPs and 73 % of internists
regarded their knowledge about UI as insufficient [22]. In
light of the above mentioned facts, it seems possible that
the actual incidence rates of UI differ from the estimates
reported by epidemiological studies.
A new treatment option by Sjostrom et al. [23], without
face-to-face contact with a physician, could be introduced
to avoid UI-related embarrassment. An Internet-based
treatment would exclude the necessity to talk to a doctor
and offer an alternative to the affected individuals.
Table 4 Use of continence pads at night in SUI patients
Grades
of SUI
The methods of protection against UI Duration of use




n n (%) n (%) n (%) n (%) n (%) (years ± SD)
1 56 9 (16.1) 35 (62.5) 1 (1.8) 10 (17.8) 1 (1.8) 3.3 ± 2.5
2 68 17 (25.0) 41 (60.3) - 9 (13.2) 1 (1.5) 6.1 ± 8.5
3 22 13 (59.1) 7 (31.8) - 2 (9.1) 9.1 ± 7.6
Total 146 39 83 1 21 2
p 0.004a 0.09b
1 patient did not provide information
alevel of significance for the Mann–Whitney U test
blevel of significance for ANOVA rank Kruskal-Wallis test, independent variable severity of SUI
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Conclusions
Our data show that women with SUI delay consultation
and proper treatment of their disability for over a decade.
It can be connected with disease specificity and lack of so-
cial acceptance for this condition. It may also be a clue for
health providers to implement programs which will in-
form the society about these problems, similarly to obes-
ity, diabetes, or other diseases. Our cross-sectional data
indicate that SUI is more severe in women with longer
SUI duration. Long-term prospective studies are needed
to understand changes in SUI severity over time. Our
study also demonstrated that not enough attention is paid
to QoL before patients seek medical advice on UI for the
first time. SUI severity is associated with disease duration
and increased use of absorbent pads. Thus, the question
about the need for continence pads can be an important
element of a screening interview. The increasing emphasis
on QoL assessment ought to make physicians ask their
patients about lower urinary tract symptoms routinely.
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